Natalizumab in multiple sclerosis: unclear patient benefits

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Natalizumab in multiple sclerosis: unclear patient benefits

Postby Thomas » Thu May 03, 2007 12:04 pm

[Natalizumab in multiple sclerosis: unclear patient benefits]
[Article in Dutch]

* Schipper JP.

Ziekenhuis Bethesda, afd. Neurologie, Dr.G.H.Amshoffweg i, 7909 AA Hoogeveen. schipper.j@bethesda.nl

Two large randomised clinical trials were published in March 2006 that evaluated the effect of natalizumab on the incidence of disease exacerbation in patients with multiple sclerosis (MS). Both trials showed that natalizumab reduces the incidence of MS exacerbations, but it is unclear whether patients ultimately benefited from treatment. It is clear that natalizumab is associated with serious adverse events, such as progressive multifocal leukoencephalopathy. Therefore, the use of natalizumab in patients with MS cannot be considered advisable at this time.

PMID: 17472115 [PubMed - in process]

<shortened url>
Thomas
Family Elder
 
Posts: 115
Joined: Mon Mar 07, 2005 4:00 pm
Location: Europe

Advertisement

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users